FDA DEVICE FACTS
EndoTool IV Cloud 1.0
Glooko, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
EndoTool Cloud is intended for use by trained healthcare professionals in inpatient care settings to assist in the management of blood glucose levels in adult and pediatric patients aged two years and older who weigh at least 12 kg. The software is intended to recommend patient-specific intravenous insulin dosing, carbohydrate dosing for recovery of or supplementation, and subcutaneous insulin dosing for the transition from intravenous therapy and for ongoing management of hyperglycemia. EndoTool Cloud generates dosing recommendations based on the prescribing healthcare provider’s orders for target glucose range, dosing mode and patient-specific clinical characteristics. The software is intended to assist healthcare professionals in adjusting and maintaining a patient’s glucose level within a configurable, clinician-determined target range. The EndoTool Cloud logic is not a substitute for clinical judgment but is intended as a decision support tool for trained healthcare professionals. Final dose decisions must be made by the healthcare professional after consideration of the patient’s overall clinical status. No medical decision should be made solely based on the recommendations provided by this software.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。